DCT

1:21-cv-00061

Amgen Inc v. Alembic Pharma Ltd

General
Filed
01/20/21
Cause of ActionInfringement
SectorBiotech
Status
Closed (06/08/21)
Patent Owner
Operating Company (W)
Nature of Suit835 ANDA
Judge
Period
PO Win Rate
--
41%
Plaintiff
Party
Defendant
Party
Attorney